IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 3 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231 | +5.0% | 5,096 | -5.0% | 0.00% | 0.0% |
| Q2 2023 | $220 | -99.9% | 5,363 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $200,000 | -3.8% | 5,396 | +56.5% | 0.00% | -75.0% |
| Q4 2019 | $208,000 | -20.0% | 3,449 | -20.6% | 0.00% | -33.3% |
| Q3 2019 | $260,000 | -15.6% | 4,342 | -9.3% | 0.01% | -25.0% |
| Q2 2019 | $308,000 | +24.7% | 4,788 | +57.6% | 0.01% | +60.0% |
| Q1 2019 | $247,000 | – | 3,039 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |